Investment management company Vulcan Value Partners recently released its fourth-quarter 2025 investor letter. A copy of the ...

Curious whether Medpace Holdings at US$610.90 is starting to look expensive or still offers value? This article walks through ...

In the latest close session, Medpace (MEDP) was down 3.01% at $588.05. This change lagged the S&P 500's 0.03% gain on the day ...

CEO August Troendle noted that Q1 2025 net awards decreased sequentially and year-over-year, resulting in a net book-to-bill ratio of 0.90. He attributed this decline to high pipeline cancellations in ...

In recent months, Medpace Holdings has reported strong organic revenue growth, high return on equity, and long-term earnings ...

Medpace has a strong financial position with high profit margins and low debt, and it has grown at a fast rate in the last five years. The company expects headwinds in 2025 in that it foresees that ...

Medpace Hldgs (NASDAQ:MEDP) is preparing to release its quarterly earnings on Monday, 2024-10-21. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Total revenue was up 14.6% on a year-over-year basis. Medpace said its backlog increased 13.7% year-over-year to $2.925 billion. The company generated $116.4 million in cash flow during the quarter.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Medpace’s massive expansion ...

Wasatch Global Investors, an asset management company, released its third-quarter 2025 “Wasatch Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. US small-cap ...

Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday. The clinical contract research organization reported earnings of $3.86, beating the consensus of ...